FDA calls idea of half-dosing Moderna COVID-19 vaccines ‘premature’

The FDA declined to immediately approve administering Moderna coronavirus vaccines in half-doses in a bid to distribute the shot wider across the U.S. population, saying the move would be “premature” and doesn’t have the full weight of science behind it.